Embedded Community-based Heart-Age Risk Education Trial in Cinese Primary Healthcare | MicrobiomeTrials← Back to trialsNCT07045363
Embedded Community-based Heart-Age Risk Education Trial in Cinese Primary Healthcare
CompletedNAINTERVENTIONAL
Trial Details
Start: 2025-08-19Est. Completion: 2025-12-01
Enrollment target: 358 participants Locations- Tinglin Community Health Center, Suzhou, Jiangsu, China
Other microbiome trials you might be interested in
Systemic SclerosisScleroderma
The purpose of this study is to evaluate the efficacy and safety of treatment with subcutaneous anifrolumab versus place…
Scottsdale, United StatesEst. completion Jan 6, 2027
High Blood Pressure
To assess the long-term safety and efficacy of the BAROSTIM NEO System in trial (NCT01471834) participants.
Calgary, CanadaEst. completion May 2012
Hematopoietic Stem Cell Transplant
Background:
Hematopoietic stem cell transplant (HSCT) is a common treatment for many cancers and other illnesses. But m…
Bethesda, United StatesEst. completion Jun 30, 2031